|
|||||
AnatrastActive Ingredient(s): Barium SulfatePossible Dosages for this and Related Drugs:Note: May Include Dosages for Drugs similar to AnatrastPaste 100%, 70% Powder for Reconstitution 100%, 92%, 94%, 95%, 96%, 97%, 98% Suspension 1.2%, 1.5%, 100%, 105%, 13%, 150%, 2%, 2.1%, 2.2%, 4.5%, 4.6%, 42%, 5%, 50%, 60%, 72%, 80%, 85%, 97% Tablet 10%, 648mg Related Drug Page(s): Related Search Results for AnatrastWebmasters or Publishers: Link To This Drug ListingCopy and Paste the HTML Code Below to Create a Link to this Listing from any Web Page or Email.Graphical Link:
Graphical Link HTML Code: Text Link: Learn About Anatrast Text Link HTML Code: Related: Anatrast pharma, Anatrast pharmacy addiction pharmaceutical, institute posting Anatrast, name condition locate interactions study Anatrast, guidelines picture forums imprint Anatrast, Anatrast precautions rx pharmacist coverage, school storage pharmaceutical treatment Anatrast, associated symptoms teaching pharmacist Anatrast, Anatrast schedule FDA guide trials, Anatrast medication. druggist drugs questions plan educate Barium Sulfate, Barium Sulfate report, Barium Sulfate company value, feedback schedule Barium Sulfate, effect study medicine find Barium Sulfate, find condition internal consultation precautions Barium Sulfate. Return to Top Start a New Discussion About this DrugThis information has been independently compiled and is for educational purposes only. It is not intended to be a substitute for professional medical advice. Please remember that the content within this community is totally compiled by users of this site. Our website displays many pages which do not contain any medical information regarding the drug name stated. These pages are only provided for the purpose of opening community discussions about that drug by our users. For more details please see the Disclaimer. This data is Copyright © 2005-2009 PrescriptionDrug-Info.com and is protected under U.S. and International Copyright laws. All Rights Reserved. Drugs/Anatrast.asp Last Updated June 26 2005 |
|||||